cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl) has been researched along with Heart Disease, Ischemic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cioffi, MA; Forbess, J; Hiramatsu, T; Mayer, JE; Miura, T; Roth, SJ | 1 |
1 other study(ies) available for cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl) and Heart Disease, Ischemic
Article | Year |
---|---|
Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts.
Topics: Animals; Biological Assay; Coronary Circulation; Endothelin Receptor Antagonists; Endothelins; Heart; Heart Arrest, Induced; Hypothermia, Induced; Myocardial Ischemia; Oxygen Consumption; Peptides, Cyclic; Receptor, Endothelin A; Reference Values; Sheep; Ventricular Function, Left | 1995 |